JOHN RUBINO
Allopathic & Osteopathic Physicians|Internal Medicine RALEIGH, NC NPI 1962543280
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NC Moderna TX, Inc. All categories
General Payments — all program years on this page
$14,626.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 273
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,915.52 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,031.31 | 40 |
| Travel and Lodging | $884.21 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Moderna TX, Inc. | $1,226.03 | 10 |
| Novo Nordisk AS | $127.65 | 6 |
| Acerta Pharma LLC | $80.30 | 4 |
| ABBVIE INC. | $72.52 | 3 |
| Astellas Pharma US Inc | $58.58 | 3 |
| Medtronic, Inc. | $38.61 | 2 |
| MEDLINE INDUSTRIES LP | $32.85 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.36 | 2 |
| Merck Sharp & Dohme Corporation | $32.01 | 2 |
| Exact Sciences Corporation | $31.70 | 2 |
| Abbott Laboratories | $30.37 | 1 |
| Otsuka America Pharmaceutical, Inc. | $28.77 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.03 | 1 |
| Endo USA, Inc. | $18.84 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.31 | 1 |
| Sumitomo Pharma America, Inc. | $17.91 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.55 | 1 |
| EISAI INC. | $15.79 | 1 |
| Amgen Inc. | $14.34 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.